People · Operator
Named in public records as an officer, director or promoter · active 2014–2019 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| BioQ Pharma Inc | — | Pharmaceuticals | Series B | $91.1M | $157.7M | 2014 |
Ron W. Pauli at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Ron W. Pauli on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| John W. Morgan | 1 | 3 |
| Mark J. Ehlert | 1 | 2 |
| Joshua W. Kriesel | 1 | 2 |
| Llew J. Keltner | 1 | 1 |
| Christopher J. Portman | 1 | 1 |
| Norvall William Jasper, Jr. | 1 | 1 |
| Richard J. Nesbit | 1 | 1 |
| Marshall S. Kriesel | 1 | 1 |
| Daniel J. Tasse | 1 | 1 |
| Christopher A. Portman | 1 | 1 |
| Richard A. Nesbit | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.